Table 1.
Demographic characteristics of the study cohort.
| Characteristics | |
| Patients, n (eyes, n) | 74 (74) |
| Sex (male:female) | 41:33 |
| Treatment status (naïve:switched) | 17:57 |
| Mean age ± SD (years) | 79.34 ± 2.83 |
| Comorbilities, n of patients | |
| None | 18 |
| Hypertension | 27 |
| Cardiovascular disease | 13 |
| Diabetes | 10 |
| Allergy | 12 |
| MN Vtype, n of eyes (naïve:switched) | |
| Type 1 | 37 (8:29) |
| Type 2 | 23 (6:17) |
| RAP | 3 (0:3) |
| PCV | 5 (3:2) |
| Mixed | 6 (1:5) |
| Weeks of follow up (months), n of patients | |
| 36 (9) | 3 |
| 38 (9.5) | 6 |
| 42 (10.5) | 2 |
| 48 (12) | 35 |
| 54 (13.5) | 5 |
| 60 (15) | 10 |
| 72 (18) | 3 |
| 84 (21) | 3 |
| ≥ 92 (≥ 23) | 3 |
SD standard deviation, MNV macular neovascularization, RAP retinal angiomatous proliferation, PCV polypoidal choroidal vasculopathy.